Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: UBS Raises Greggs; Peel Hunt Lifts Chesnara

Wed, 28th Aug 2019 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday afternoon and Wednesday morning:

----------

FTSE 100

----------

KEPLER CHEUVREUX RAISES GLAXOSMITHKLINE PRICE TARGET TO 1600 (1540) PENCE - 'HOLD'

----------

JEFFERIES CUTS SPIRAX-SARCO PRICE TARGET TO 7855 (8525) PENCE - 'HOLD'

----------

GOLDMAN RAISES COMPASS GROUP PRICE TARGET TO 1890 (1680) PENCE - 'SELL'

----------

BARCLAYS CUTS BUNZL PRICE TARGET TO 2400 (2550) PENCE - 'OVERWEIGHT'

----------

INDEPENDENT RESEARCH CUTS BP PRICE TARGET TO 550 (590) PENCE - 'HOLD'

----------

INDEPENDENT RESEARCH CUTS BHP GROUP PRICE TARGET TO 1925 (2100) PENCE - 'HOLD'

----------

JPMORGAN REMOVES BHP FROM EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST

----------

JPMORGAN ADDS GLENCORE TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST

----------

JPMORGAN REMOVES BRITISH AMERICAN TOBACCO FROM EUROPEAN BEST EQUITY OVERWEIGHT IDEAS LIST

----------

JPMORGAN ADDS PEARSON TO EUROPEAN BEST EQUITY OVERWEIGHT IDEAS LIST

----------

JPMORGAN ADDS ADMIRAL TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS LIST

----------

JPMORGAN REMOVES FERGUSON FROM EUROPEAN BEST EQUITY OVERWEIGHT IDEAS-LIST

----------

FTSE 250

----------

UBS RAISES GREGGS TO 'BUY' ('NEUTRAL') - TARGET 2300 (1880) PENCE

----------

UBS RAISES POLYMETAL PRICE TARGET TO 1300 (1200) PENCE - 'BUY'

----------

GOLDMAN RAISES POLYMETAL PRICE TARGET TO 1310 (1300) PENCE - 'BUY'

----------

JPMORGAN CUTS PLAYTECH PRICE TARGET TO 585 (603) PENCE - 'OVERWEIGHT'

----------

JPMORGAN ADDS JOHN WOOD GROUP TO EUROPEAN BEST EQUITY UNDERWEIGHT IDEAS-LIST

----------

RBC CUTS JOHN WOOD GROUP PRICE TARGET TO 600 (670) PENCE - 'OUTPERFORM'

----------

JEFFERIES RAISES DIPLOMA PRICE TARGET TO 1800 (1790) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

PEEL HUNT RAISES CHESNARA TO 'HOLD' ('REDUCE')

----------

JPMORGAN RAISES DAILY MAIL PRICE TARGET TO 950 (870) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS KINGSPAN GROUP PRICE TARGET TO 4100 (4500) PENCE - 'EQUAL WEIGHT'

----------

More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.